Filing Details

Accession Number:
0001062993-22-023503
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-07 18:56:32
Reporting Period:
2022-12-05
Accepted Time:
2022-12-07 18:56:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1624326 Pavmed Inc. PAVM Surgical & Medical Instruments & Apparatus (3841) 471214177
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1665434 J Michael Glennon One Grand Central Place, Suite 4600
New York NY 10165
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-05 62,000 $0.69 62,000 No 4 P Direct
Common Stock Acquisiton 2022-12-06 88,000 $0.64 150,000 No 4 P Direct
Common Stock Acquisiton 2022-12-07 100,000 $0.62 250,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.67 to $0.6984 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.5930 to $0.6746 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6122 to $0.6382 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.